Raise Awareness

Addressing Apathy and Other Mood Disorders in Parkinson’s

Man on couch

Apathy, the feeling of having lost your zest for life, is one of the most challenging symptoms of Parkinson’s disease (PD). Apathy can make it a struggle to engage with others, take part in daily activities and manage PD symptoms. Along with depression and anxiety, apathy in PD is often overlooked and undertreated. Learning the symptoms of apathy, how it can work alongside other mood disorders and management strategies can support your mental well-being. 

The following article is based on a  Parkinson’s Foundation Expert Briefing about apathy and mental health in Parkinson’s, hosted by Aaron Malina, PhD, ABPP, clinical neuropsychologist at Northwestern Medicine Lake Forest Hospital, a Parkinson’s Foundation Center of Excellence. 

How PD Brain Changes Affect Mood  

Apathy, along with anxiety, depression and cognitive changes, can be common in Parkinson’s. The brain chemistry changes that cause movement symptoms in Parkinson’s can also impact mood. Some people might experience mood disorders even before movement symptoms start. 

Parkinson’s impacts areas deep within the brain, disturbing complex communication networks. These changes are linked to a decrease in the production of: 

  • Dopamine: chemical responsible for movement and mood 

  • Noradrenaline: a substance related to movement, mood, cognitive health and more  

  • Serotonin: chemical that helps regulates emotions  

  • Acetylcholine: chemical that helps with thinking abilities 

Understanding Apathy 

Apathy impacts 16 to 46% of people with Parkinson’s. Apathy can occur on its own, as a component of other psychiatric conditions, such as depression, or in neurological diseases including Parkinson’s.  

In Parkinson’s, apathy is a motivation disorder due to disruption of the brain’s networks. Although outside factors can influence apathy, it is not an emotional reaction and is not due to thinking difficulties or emotional distress.  

People with apathy have difficulty processing, identifying and differentiating between good or bad outcomes. This makes it difficult for them to respond accordingly. Apathy can make it challenging to attend healthcare appointments, take medications or practice self-care. In extreme cases, a person with apathy may not move or speak.  

A person experiencing apathy may show little emotional expression or seem indifferent, disinterested or uncaring. This can be compounded by PD symptoms like masked face, making it harder for someone to communicate their emotions.  

Types of Apathy & Treatments  

Apathy symptoms are caused by a dysfunction deep in the midbrain and the frontal lobes of the brain — which process emotional information, drive, movement and behavior. People with PD of increased age, with less health education, who experience depression, cognitive impairment or rapid eye movement sleep behavior disorder, as well as those with advanced Parkinson’s, are at greater risk of developing apathy. 

Your doctor may ask you to fill out a questionnaire or interview you to understand how apathy impacts your life and to identify the best therapy.  

Apathy can show up in four ways: 

  1. Behavioral symptoms: include lack of initiative and productivity. Causes a person to become more dependent on others. Dopamine agonists may help. However, these medications are associated with impulse control disorders.  

  1. Emotional symptoms: cause a lack of response to positive and negative events, less concern for what's going on with others, less affection and general indifference. In addition to dopamine agonists, methylphenidate or serotonergic agents might be prescribed.  

  1. Cognitive symptoms: impact a person’s interest in learning new things and the ability to plan, organize or participate in activities. Cholinesterase inhibitors might be prescribed.  

  1. Social engagement: diminishes with apathy. A lack of interest in participating in relationships can impact significant other, family members and friends. 

In addition to medications, exercise, social engagement, mindfulness and cognitive therapy play a major role in addressing apathy. Noninvasive transcranial magnetic stimulation (TMS) therapy, which stimulates cells in the brain, might improve symptoms. Deep brain stimulation (DBS), a neurological surgery to treat some Parkinson's symptoms, can also sometimes improve apathy.  

Apathy and Cognitive Change 

Apathy may be a predictor of cognitive change in Parkinson’s. Many people with PD experience mild cognitive impairment, which can impact executive function — a person’s ability to plan, organize and problem solve. People with more significant cognitive change can experience greater apathy. 

Splitting Apathy from Depression 

Although apathy and depression occur in different parts of the frontal lobes, both can overlap. Symptoms seen in both apathy and depression include: 

  • Slow movement   

  • Inability to experience joy  

  • Lack of energy  

  • Decreased enthusiasm  

Depression impacts 50% of people with Parkinson’s. While depression can cause sadness or irritability, its onset does not require a sad or a traumatic event. Depression can cause changes in weight, appetite and sleep. A person with depression may experience a lack of self-worth, guilt or thoughts of self-harm or suicide.  

People with more movement symptoms and women are at greater risk for depression in PD. People with advanced Parkinson’s, certain genetic subtypes of PD or cognitive impairment are also more prone to depression. 

Anxiety & Cognition  

Anxiety, excessive worry that is challenging to control, can occur in up to a third of people with Parkinson’s and can impact cognition and physical function. A person with anxiety may feel sad, irritable, edgy or restless, may tire or fatigue easily, have trouble concentrating or sleeping, or have increased muscle aches or soreness. Some people with Parkinson's are diagnosed with anxiety along with depression.  

Social phobia, fear or anxiety about social situations, is a common anxiety disorder in PD. A person experiencing social phobia fears being perceived negatively by others and avoids social situations or endures them with intense fear.  

People who develop Parkinson’s at a younger age are more prone to anxiety. Anxiety also tends to worsen for people with PD during “off” times — when the effect of levodopa medication wears off. 

Seeking Treatment 

Regular screening for mood and cognitive change is an important aspect of PD care. However, not every Parkinson’s doctor asks about mental health or screens for mood changes. If you experience any signs of apathy, depression, anxiety or cognitive change, talk to your doctor.  

Medication therapy is often used in combination with talk-based (cognitive behavioral) therapy to manage mental well-being in PD. The medications most used to treat depression and anxiety are SSRIs (selective serotonin reuptake inhibitors) and SNRIs (serotonin and norepinephrine reuptake inhibitors). Cognitive behavioral therapy helps a person understand how their mood symptoms impact how they're thinking and feeling and gives them tools to address symptoms. 

Regular exercise or movement is also essential to Parkinson’s management and mental well-being.   

Learn More 

Discover more about emotional health in Parkinson’s with these resources: 

Videos & Webinars

Expert Briefing: More Than PD - Managing Multiple Chronic Conditions

October 9, 2024

Parkinson’s is a complex disease with many symptoms that can lead to complications, such as falls and pneumonia. At the same time, people with Parkinson’s disease are at risk for other medical conditions that occur in the general population, including heart disease, arthritis, and diabetes.  Learn about coordination of care, medication management and what to know to achieve the best long-term outcomes.

Download Slides

Additional Resources

Presenter

Christina Swan, MD, PhD
Assistant Professor of Neurological Sciences & Fellowship Director 
Division of Movement Disorders
Rush University Medical Center, a Parkinson's Foundation Center of Excellence

Advancing Research

Mi Historia con EP – Carla Velastegui

Carla Velastegui

Desde que tenía 15 años, Carla Velastegui ha sido la principal aliada en el cuidado de su madre, Gina, a quien diagnosticaron la enfermedad de Parkinson de inicio temprano (EPIT) en sus cuarentas.  

"Dar cuidados es una parte esencial de quien soy", dice Carla. "Ayudar a mi madre a manejar su Parkinson ha sido una constante durante gran parte de mi vida. Cuando era más joven, la gente siempre se sorprendía de que yo asumiera responsabilidades de cuidadora. Por eso me apasiona generar conciencia y abordar los complejos desafíos a los que se enfrentan los cuidadores en sus comunidades, lugares de trabajo y sistemas de salud al cuidar de sus seres queridos. 

Carla Velastegui and mom wedding picture

Cuando su padre asumió el papel de único proveedor de la familia, Carla se convirtió naturalmente en la persona que acompañaba a su madre a las citas con el médico. Traducía para su madre, cuya lengua materna era el español y se aseguraba de que entendiera perfectamente su plan de cuidados y se comprometiera con él, además de proporcionarle apoyo para la continuidad de los cuidados. Los médicos cuestionaban con frecuencia su participación en el cuidado de su madre, lo que ha convertido a Carla en una apasionada defensora de los aliados en el cuidado, especialmente de los más jóvenes. 

"Es sumamente importante que los jóvenes aliados en el cuidado sean reconocidos, apoyados y valorados por los proveedores, especialmente en el caso de las comunidades inmigrantes, donde existen barreras del lenguaje", dijo. "Necesitamos garantizar la calidad y la continuidad de los cuidados, especialmente cuando se cuida de alguien con una enfermedad crónica como el Parkinson"

Read Carla's Story in English

We believe in empowerment through education for the PD community, through English and Spanish resources.

Carla Velastegui and family

Ahora, Carla comparte los cuidados con su padre, que pudo jubilarse anticipadamente. Pero a lo largo de las etapas inicial y media de su carrera, compaginó el cuidado de su madre con la construcción de su propio camino. Carla comenzó su carrera en el ámbito de la salud digital trabajando con empresas emergentes en fase inicial. Le encantaba el trabajo y lo encontraba apasionante, pero el desafío de mantener un equilibrio saludable entre trabajo y vida personal, combinado con la falta de un apoyo estructurado para los aliados en el cuidado, la impulsó a buscar un puesto en un sector diferente, uno que ofreciera mejores recursos para su crecimiento profesional y la evolución de sus responsabilidades como cuidadora.  

A través de estas experiencias, Carla desarrolló una pasión por aprovechar la tecnología para mejorar la coordinación de la atención y ampliar su alcance, creando un continuo de atención para los pacientes y su círculo de cuidados. "Siempre estoy explorando cómo la tecnología puede ayudar a los aliados en el cuidado como yo y a las personas que viven con Parkinson, ya sea transfiriendo tareas, centralizando la información o simplificando el manejo de la atención. La tecnología me ayuda a manejar las necesidades de mi madre de forma más eficaz y a centrarme en lo que de verdad importa: proporcionarle cuidados con compasión." 

A la par de sus tareas de aliada en el cuidado, Carla sigue encontrando maneras para ser una compañera y amiga solidaria de quienes forman parte de su red de atención y apoyo. "Tener conversaciones abiertas con mi pareja y mis amigos sobre lo que me requiere ser aliada en el cuidado ha sido importante", dijo Carla. "A veces necesito más flexibilidad con los planes porque la situación del cuidado de mi madre puede cambiar inesperadamente. También he aprendido a comunicar con más eficacia los apoyos que necesito de quienes me rodean. No puedo hacerlo sola". 

Ser transparente con sus padres acerca de las expectativas y los planes ha sido clave a medida que navegan como familia por el cuidado del Parkinson para su madre. “Pero no siempre ha sido fácil”, dijo Carla y recomienda a las personas recién diagnosticadas que se tomen el tiempo necesario para hablar de finanzas y de cosas que podrían entrar en juego más adelante, como mudarse a una casa que pueda adaptarse mejor a los síntomas del Parkinson. 

"Cuando se recibe por primera vez un diagnóstico, puede sentirse abrumado y asustado", dijo. "Puede parecer difícil, pero es importante hablar del futuro desde un principio. En retrospectiva, ojalá hubiéramos tenido esas conversaciones antes, para tener más tiempo de planificar y prepararnos para cosas como la jubilación anticipada de mi papá o los recortes realizados por mis padres. Conversaciones como ésta también han sido importantes para mí a la hora de planificar mi propio futuro, para poder equilibrar el apoyo a mi mamá y seguir trabajando para lograr mis propios objetivos sin que surja el resentimiento o que sienta que mi vida está en pausa." 

Carla también aprendió que dedicarse tiempo a sí misma es esencial para evitarel agotamiento. Hace unos años, llegó a un punto de quiebre y empezó a dedicar tiempo cada semana para desconectarse y hacer algo de lo que disfruta. 

"Darme cuenta de que mi bienestar es igual de importante ha sido una lección esencial", dijo.  "Dedicar tiempo a la terapia y a las aficiones como el senderismo y el paddleboard, donde puedo desconectarme, han sido de gran ayuda. Me recuerdo a mí misma que, si no estoy bien, mental, emocional y físicamente, entonces no soy capaz de cuidar bien de mi mamá". 

¡Conzoca a Carla en la Cumbre para Cuidadores en español!

Acompáñenos el 27 de noviembre en nuestro webinar Cumbre para Cuidadores, con expertos en la EP y aliados en el cuidado, como Carla.

Carla Velastegui and mom boat

Abogar por los aliados en el cuidado es una fuerza motora para Carla. Participa con el Toronto Western Hospital, un Centro de Excelencia de la Parkinson’s Foundation donde su madre recibe atención, y es miembro del Consejo Asesor de Personas con Parkinson  (People with Parkinson’s Advisory Council) de la Parkinson's Foundation, donde es una de los dos hijos adultos que ayudan a un progenitor con Parkinson.  

La conexión con la Parkinson’s Foundation ha sido una importante fuente de apoyo para Carla como aliada en el cuidado. Hace referencia regularmente a Parkinson.org para obtener orientación, sobre todo cuando los síntomas evolucionan y la condición progresa. Los recursos en español de la Fundación han cambiado la vida de su madre, quien siente que puede tener más control sobre su experiencia con el Parkinson al poder leer útiles artículos y ver videos en su propio idioma. 

"Con el Parkinson, cada día es un día nuevo y único, y algunos son más difíciles que otros para mi mamá y para mí como su aliada en el cuidado", dijo. "Puede ser difícil compaginarlo todo, sobre todo con un trabajo a tiempo completo y buscando lograr sueños e hitos personales.  Uno de mis sueños es que algún día los centros de trabajo y de salud reconozcan la prestación de cuidados del mismo modo que reconocen el permiso parental. Hasta entonces, seguiré abogando y haciendo todo lo que pueda para concientizar y hacer realidad esa visión". 

Read Carla’s Story in English

Para más consejos sobre cómo navegar por el recorrido como aliado en el cuidado, visite Parkinson.org/Caregiving. 

Educational Events

Navigating Advancing Needs

10:30 am to 2:00 pm EST
Free
Navigating Advancing Needs

In-person check-in starts at 10:30 a.m. and the program begins at 11:00 a.m.

Navigating Parkinson’s disease involves looking ahead, learning and adjusting as symptoms and needs change. This program addresses some of the challenges of advancing PD and explores strategies to prepare for the future,including how to evolve your care plans and treatments throughout progression so you can live your best life with PD now. We will also have a segment on the newest advancements In Parkinson's Research. 

Speakers 
Dr. Anna DePold Hohler, FAAN, Chair, Department of Neurology
St. Elizabeth’s Medical Center / Boston Medical Center

Dr. Anindita Deb, FAAN, Co-Chief of the Movement Disorders Division
UMass Memorial

Dr. Kara Smith, MSCI, FAAN, Co-Chief of the Movement Disorders Division
UMass Memorial

There is no charge to attend, but registration is required. This program is open to people with Parkinson's, their family, friends and the community.

This event is made possible by Gold Sponsor, ACADIA Pharmaceuticals.

Upcoming Events

Videos & Webinars

Exploring Financial and Estate Planning

June 19, 2024

Financial and estate planning can seem overwhelming and many just don’t understand what it is and why it’s important. Understand what estate planning is, what’s involved, and how to begin the process of protecting your assets to ensure you and your loved ones are cared for. Don’t leave your future to chance and gain the knowledge to make informed decisions.

Presenter

Colleen Ceh Becvar, Gerontologist, Owner, Certified Care Manager
Trinity Advocacy Group, LLC
Midwest Chapter of Aging Life Care Association Board of Directors

Videos & Webinars

Resources for Veterans with Parkinson's 2024

September 19, 2024

More than 110,000 veterans with Parkinson’s disease receive care through the U.S. Department of Affairs (VA).  Many U.S. military veterans with Parkinson’s have access to specialized medical care and financial assistance through the VA. During this webinar, we will dive into an exploration of the extensive resources and dedicated support services that Veterans have access to through the VA and the Parkinson’s Foundation.

Download Slides

Additional Resources

Presenters

Gretchen Glenn, LCSW
Corporal Michael J. Crescenz VA Medical Center
Philadelphia PADRECC
Social Worker/Associate Director of Education
National VA PD Consortium Education Subcommittee Chairperson

Johnnie Bourque
Veteran Services Representative
Floater Northern Region

Videos & Webinars

Expert Briefing: Communication Strategies for Optimal Success with PD

September 17, 2019

Conversation is the primary mechanism by which humans create and maintain relationships. Yet, in the context of Parkinson’s disease (and typical aging) changes in speech, facial expressions, cognition, voice, and hearing can interfere with communicating messages and creating meaningful connections in conversations between individuals with Parkinson’s disease and their partners. These changes significantly impact the perceived burden (social, emotional, physical) and practical aspects of living with Parkinson’s disease. Dr. Roberts will focus on the multidimensional nature of conversation difficulties in the context of living with Parkinson’s disease and will discuss communication strategies for optimizing successful conversation interactions.

Presenter

Angela Roberts, PhD
Roxelyn and Richard Pepper Department of Communication Sciences and Disorders
Northwestern University (Parkinson’s Foundation Center of Excellence)

Advancing Research

Meet the Researcher Shining a Light on Parkinson’s Treatment-Induced Impulsivity

Xiaowen Zhuang, PhD

Dopamine replacement therapies, such as dopamine agonists and the commonly used drug levodopa, can alleviate some of the more debilitating movement symptoms of Parkinson’s disease (PD), restoring precious autonomy and quality of life to those that need it. However, these therapies are not without side effects, one of which is the potential to develop an impulse control disorder. 

Up to 40% of people who take dopamine-replacing drugs for their PD experience impulse control disorders (ICDs). ICDs can present themselves in many ways, including gambling addictions or excessive eating.  

Xiaowen Zhuang, PhD, a recipient of a Parkinson’s Foundation Launch Award, wants to better understand the neuroscience behind this medication-induced impulsivity so that we can improve future treatments to avoid this side effect altogether. 

Dr. Zhuang will study ICD using mice, measuring what is known as delay discounting behavior, which is how much a subject is willing to ignore an immediate smaller award (like treats) and wait for a larger award instead. She uses tools called operant boxes that allow her to train mice on this “small award now vs. larger reward later” scenario and collect data on how their impulsivity changes in different conditions. 

Delay Discounting Behavior

The degree to which a delay for greater reward discounts the value of that award compared to a smaller, immediate one in the mind of the decision-maker. 

  • Low impulsivity = Low delay discounting > Willing to wait for larger reward  
  • High impulsivity/ICD = High delay discounting > More likely to take immediate, smaller reward 

Once the mice are trained, Dr. Zhuang will then utilize a cutting-edge scientific method called optogenetics to turn on or off certain decision-associated neurons in the brain and observe how that affects the mice’s impulsivity. From these experiments, she hopes to home in on the specific parts of the brain connected to ICD and discover how exactly they are affected by PD medications. This knowledge could then guide the development of future treatments where such impulsivity symptoms are no longer a concern. 

Dr. Zhuang’s interest in this topic began once she joined the lab of Alexandra Nelson, MD, PhD, at the University of California, San Francisco, CA, in 2020. 

“Discussions with my mentor, Dr. Nelson, deepened my understanding of the severe complications experienced by Parkinson's disease patients, among which impulse control disorder is a salient one,” Dr. Zhuang said. “These severe consequences intensified my desire to learn new skill sets to dissect the circuit mechanisms.” 

Shortly after joining, the COVID-19 pandemic forced all researchers away from labs and into their homes. But this didn’t stop Dr. Zhuang’s scientific enthusiasm.  

“While she had little coding experience or familiarity with operant behavior prior to joining my lab, with only modest guidance and the loan of a power drill and soldering iron, she built custom operant boxes at home, wrote code to run them, and developed a plan for progressive training and testing with a delay discounting task,” said Dr. Nelson. “She tested her boxes over Zoom, using a fuzzy mouse toy to trigger nose pokes.” 

Back in the lab and ready to begin her Foundation-supported research, Dr. Zhuang is excited about how her research may improve the lives of those relying on PD medicine.  

“Despite its prevalence, our understanding of ICD’s cause is limited, and effective treatments or interventions are yet to be discovered,” she said. “My research could pave the way for new treatments for Parkinson's disease that help manage symptoms more effectively without leading to these impulse control issues.” 

Meet more Parkinson’s researchers! Explore our My PD Stories featuring PD researchers. 

Science News

New Study Further Personalizes Deep Brain Stimulation

Parkinson's Foundation Science News blogs

Deep brain stimulation (DBS) is a surgical treatment that provides relief to people with Parkinson's disease (PD) who experience movement symptoms and medication side effects. Since its U.S. Food and Drug Administration (FDA) approval to treat PD symptoms in 2002, DBS can help reduce medication needs and stabilize symptoms. PD symptom severity often varies throughout the day — because DBS provides constant electrical stimulation, there can be times when it is too much or too little, which limits its effectiveness. 

A recent study has developed a new approach, known as adaptive DBS, which has the potential to further personalize DBS treatment for Parkinson's. It was recently tested in a small clinical trial reported in Nature Medicine. 

Utilizing custom computer algorithms and artificial intelligence (AI), adaptive DBS can detect symptom changes in real time by monitoring brain activity that is specific to each participant. When it detects changes, the system delivers precisely calibrated electrical pulses to counteract these shifts. 

The system delivers more electrical stimulation during periods of stiffness (bradykinesia) and less during phases of involuntary movement (dyskinesia). It also adjusts stimulation based on the effectiveness of levodopa medication, providing more stimulation when the medication wears off and less when it's active.  

About the Study & Results

deep brain stimulation

The clinical trial enrolled four participants who were diagnosed with Parkinson’s at least six years earlier. Each participant underwent conventional DBS surgery. Researchers collected brain activity data for each participant, then used that data to create personalized algorithms to detect and respond to symptom fluctuations. Months after the initial DBS surgery, each participant was switched to adaptive DBS. 

To compare the two types of DBS, participants switched between conventional stimulation and the personalized version every two to seven days over a period of two months (one month spent with each stimulation type). Neither the participants nor most of the researchers knew which type of stimulation was being delivered at any time. Participants reported their symptoms daily, and wearable monitors detected changes in their movement symptoms. 

All four participants experienced nearly a 50% reduction in time spent with their most troublesome symptom when adaptive DBS was active compared to conventional stimulation. They reported that their worst symptoms went from persisting for about 25% of their day down to about 12%. Additionally, adaptive DBS did not worsen other PD-related symptoms. Overall, participants reported an improved quality of life with adaptive DBS.  

By dynamically adjusting stimulation parameters based on real-time brain signals, adaptive DBS appears to offer a more personalized and effective treatment for Parkinson's than conventional DBS. 

Highlights 

  • A clinical trial enrolled four participants to test a surgical treatment called adaptive DBS that detects and responds to brain activity to provide individualized and customized stimulation to help with Parkinson’s symptoms. 

  • All four participants experienced a nearly 50% reduction in time spent with their most troublesome symptom when adaptive DBS was active. 

  • Adaptive DBS did not worsen other PD-related symptoms. 

  • Participants reported improved quality of life with adaptive DBS compared to conventional DBS. 

What does this mean? 

Adaptive DBS may be an evolved version of DBS treatment for improving movement symptoms of Parkinson’s. The study finds that using new technology can further personalize DBS currents and make DBS even more effective in treating troublesome PD symptoms. However, developing the customized algorithms for each participant was time consuming in this small study, and it will take time before it becomes widely available. 

What do these findings mean to the people with PD right now? 

It’s important to keep in mind that this was a small study of only four participants. The study, and its technology will need to be replicated on a much larger scale. Still, the study findings are exciting and bring hope for the PD community, as proven by its media coverage. The concept of adaptive DBS may eventually become the standard for DBS treatment, and with further development and refinement, people with conventional DBS may be able to use adaptive DBS in the future.  

Adaptive DBS is still in testing and it does not have widespread availability. People should talk to their doctors about their treatment options and if they have DBS, ask doctors or their care team to inform them if a similar adaptive DBS study begins to recruit.  

Get Involved with Parkinson's Research

Explore the different opportunities to get involved with Parkinson’s research.

Advancing Research

Parkinson’s Foundation Presents Five Findings at International Congress of Parkinson’s Disease and Movement Disorders®

Researcher in lab

Every year thousands of Parkinson’s disease (PD) experts and researchers share research findings that have the potential to help people living with Parkinson’s at the International Congress of Parkinson’s Disease and Movement Disorders. This year the conference took place from September 27 to October 1 in Philadelphia, PA.  

The Parkinson’s Foundations shared five new Parkinson’s studies, revealing new information about genetics research, care and our work with the Black and African American community. These findings offer new hope for people living with PD and caregivers alike.  

Explore the five research findings the Parkinson’s Foundation shared with the international PD community below:   

SEE ALL POSTERS

1. Expanding the PD Generation Study to Increase Clinical Genetic Testing and Counseling Using Whole Genome Sequencing Among Diverse Parkinson’s Populations 

PD GENEration: Mapping the Future of Parkinson’s disease is a Parkinson’s Foundation research study that offers genetic testing and counseling, in English and Spanish, to people with Parkinson’s through a whole genome sequencing platform. This study aims to simplify access to clinical genetic testing to people with PD and offer educational materials to clinicians on PD genetics. 

Key Takeaways: 

  • The study has enrolled 18,003 participants, as of September 2024. 

  • The study has expanded to five countries from Latin America (Colombia, Chile, Peru, Mexico, Ecuador), Israel, Canada, and 10 additional sites in the U.S. that focus on underrepresented populations. 

  • 12.2% of people with Parkinson’s, who have completed testing, tested positive on the PD GENEration 7-gene panel. 

  • By providing genetic testing to all those interested and from all backgrounds, the study helps inform care, diversify the data, help engage people in research, and qualify more for enrollment in clinical trials for PD. 

PD GENEration goals include helping accelerate clinical trials in PD, improving PD care and research and empowering people with PD and their care teams. 

Learn more & enroll in PD GENEration.

2. Engagement of the Black and African American Community in PD Genetics Research 

Advancements in understanding the biological pathways of Parkinson’s have largely been focused on people of European ancestry. There is a critical need to understand genetic differences across populations, including people with African ancestry. The Parkinson’s Foundation partnered with Morehouse School of Medicine, a historically Black institution of medicine to improve inclusion in PD GENEration, prioritize PD awareness, education and resources; and tailor our research advocacy training program — the Learning Institute.   

Key Takeaways: 

  • Through this partnership with Morehouse School of Medicine, from November 2021 to March 2024, 157 Black and African American participants enrolled in PD GENEration.  

  • 14 community education events were held, including the Learning Institute in September 2023. 

  • Media was developed and utilized to expand reach and included two webinars, five podcasts and six blogs/news articles.  

Establishing partnerships with trusted sources of the Black community is critical to providing equitable access to PD education and resources, including PD GENEration. Focusing on diversity and inclusion in PD GENEration will accelerate breakthroughs towards a cure for PD.     

Learn more about our impactful partnership with Morehouse. 

3. Benefits of Parkinson’s Team Training Are Maintained Long-term 

The goal of Parkinson’s Foundation Team Training is to provide more coordinated and complete patient-centered care to improve the quality of life of people with PD and caregivers. Our study aimed to demonstrate the effectiveness of the training program and determine if the benefits of Team Training are maintained long-term. 

Key Takeaways: 

  • Through Team Training, team members become more effective in delivering better interprofessional, patient-centered care.  

  • Results showed significant and sustained improvements in: 

  • Healthcare professional confidence in various measures of providing care 

  • Team coordination working with persons with PD and their care partners 

  • Understanding of the other team member roles and how team members can assist in the care of persons with PD and their care partners. 

  • The effectiveness of the Team Training program’s education is maintained and sustained long term. Better care leads to better lives for those living with PD and their care partners. 

Parkinson’s Foundation Team Training provides a continuing education program for healthcare professionals to learn more about PD and how to develop and maintain an effective PD interprofessional team.  

Explore our Learning Lab courses, designed for healthcare professionals.  

4. Engage, Educate and Empower: Parkinson’s Research Advocates from the Black and African American Community  

Black and African American people with Parkinson's face significant disparities in care, including delays in diagnosis and treatment, limited access to care and historical exclusion from research. To address these challenges, the Parkinson’s Foundation Research Advocacy Training program, the Learning Institute, was tailored to engage, educate, and empower the Black community in Parkinson’s research. 

Key Takeaways: 

  • The Learning Institute was held in September 2023. 33 people from the Black community were trained in research advocacy.  

  • Many research advocates felt prepared to begin research advocacy (79%) and most felt excited about the work they can do as a research advocate (83%). 

  • To date, 17 advocacy tasks were completed by 26 research advocates, including presentations at local churches and health fairs, panelists at a Parkinson’s Foundation community-based program, and partnerships with researchers.  

The Learning Institute empowered African Americans living with PD to become advocates for community outreach and engagement. This program has the potential to drive meaningful change, enhance health equity, and improve outcomes for those living with PD in the Black and African American community. 

Learn more about our research advocates. 

5. Hospital Care Learning Collaborative: Sharing Strategies to address the Parkinson’s Foundation Inpatient Clinical Care Standards 

With the launch of the Parkinson’s Foundation Hospital Care Learning Collaborative, the Foundation in partnership with healthcare leaders, clinicians and institutions, aims to eliminate preventable harm and promote higher reliability in care for people with Parkinson’s in the hospital. The Learning Collaborative work to implement quality improvement projects focused on improving hospital safety for people with PD. Participants shared strategies and best practices to address the hospital care standards, as outlined in the Parkinson’s Foundation Hospital Care Recommendations.  

Key Takeaways: 

  • A framework to work with the hospital IT team to request adjustments to the Electronic Health Record, including the ability to customize times for Parkinson’s medication orders. 

  • Strategies to avoid medication delays in the event of safety concerns due to swallowing challenges (dysphagia), including the use of crushed Parkinson’s medication and an automated trigger for a Speech Language Pathologist evaluation.  

  • The use of an Electronic Health Record alert when unsafe medications are ordered, offering alternatives that are already approved by the hospital Pharmaceutical & Therapeutics committee. 

The Parkinson’s Foundation is committed to improving hospital safety for people with PD. In addition to our Hospital Safety Guide, a resource for people with Parkinson's and care partners, the Foundation works with hospitals and health systems to help promote awareness and delivery of the best care for the Parkinson’s community.  

Read and download the Hospital Safety Guide today. 

SEE ALL POSTERS  

Stay up to date with Parkinson’s Foundation through our Parkinson’s Today blog.  

Back to Top